Diabetes mellitus (DM), a chronic metabolic disease characterised by elevated levels of
blood glucose, is among the most common chronic diseases. The incidence and prevalence …

Metabolic syndrome (MetS) is a well‐recognized cluster of cardiovascular (CV) risk factors
including obesity, hypertension, dyslipidemia, and hyperglycaemia, closely associated with …

BACKGROUND Metabolic syndrome (MetS) and benign prostate hyperplasia (BPH)/low
urinary tract symptoms (LUTS) are often comorbid. Chronic inflammation is one of the …

BACKGROUND Metabolic syndrome (MetS) and benign prostate hyperplasia (BPH) are
often comorbid. Chronic inflammation, a determinant pathogenic factor for BPH, is a putative …

The metabolic syndrome is common in countries with Western lifestyles. It comprises a
number of disorders—including insulin resistance, hypertension and obesity—that all act as …

The etiology of benign prostatic hyperplasia [BPH] in elderly men has intrigued anatomists,
pathologists and scientists for centuries. Studies of morbid anatomy, clinical observations …

No previous study has evaluated systematically the relationship between metabolic
syndrome (MetS) and prostate-related symptoms and signs in young infertile men. We …

The guest editors of this issue are pleased to present this compendium of research and
review articles focusing on the role of oxidative stress and inflammation in diabetes and …

Abstract Cryptolepis sanguinolenta (Lindl.) Schltr (Periplocaceae), has a longstanding
traditional use in the treatment of malaria in the West African region. Recent evidence …

Benign prostatic hyperplasia and hypertension are common age-related comorbidities.
Although the etiology of benign prostatic hyperplasia (BPH) is still largely unresolved and …